HomeCompareFFNOX vs MRK

FFNOX vs MRK: Dividend Comparison 2026

FFNOX yields 3.82% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $5.1K in total portfolio value
10 years
FFNOX
FFNOX
● Live price
3.82%
Share price
$64.17
Annual div
$2.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$488.92
Full FFNOX calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — FFNOX vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFFNOXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FFNOX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FFNOX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FFNOX
Annual income on $10K today (after 15% tax)
$325.06/yr
After 10yr DRIP, annual income (after tax)
$415.58/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $392.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FFNOX + MRK for your $10,000?

FFNOX: 50%MRK: 50%
100% MRK50/50100% FFNOX
Portfolio after 10yr
$28.2K
Annual income
$719.61/yr
Blended yield
2.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FFNOX
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FFNOX buys
0
MRK buys
0
No recent congressional trades found for FFNOX or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFFNOXMRK
Forward yield3.82%3.25%
Annual dividend / share$2.45$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$25.6K$30.7K
Annual income after 10y$488.92$950.29
Total dividends collected$4.4K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FFNOX vs MRK ($10,000, DRIP)

YearFFNOX PortfolioFFNOX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,082$382.42$11,192$351.54$110.00MRK
2$12,254$396.09$12,524$392.70$270.00MRK
3$13,521$409.32$14,015$438.65$494.00MRK
4$14,890$422.10$15,682$489.96$792.00MRK
5$16,367$434.41$17,547$547.23$1.2KMRK
6$17,959$446.26$19,632$611.16$1.7KMRK
7$19,673$457.63$21,963$682.53$2.3KMRK
8$21,519$468.53$24,571$762.18$3.1KMRK
9$23,504$478.96$27,486$851.08$4.0KMRK
10$25,639$488.92$30,745$950.29$5.1KMRK

FFNOX vs MRK: Complete Analysis 2026

FFNOXStock

The fund invests in a combination of four Fidelity® stock and bond index funds (underlying Fidelity® Funds) using an asset allocation strategy designed for investors seeking a broadly diversified, index-based investment. It allocates approximately 48% of its assets in Fidelity® 500 Index Fund, 12% in Fidelity® Extended Market Index Fund, 25% in Fidelity® International Index Fund, and 15% in Fidelity® U.S. Bond Index Fund.

Full FFNOX Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this FFNOX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FFNOX vs SCHDFFNOX vs JEPIFFNOX vs OFFNOX vs KOFFNOX vs MAINFFNOX vs JNJFFNOX vs ABBVFFNOX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.